Démythifier la spasticité en première ligne

James Milligan, Kayla Ryan, Joseph Lee, James Milligan, Kayla Ryan, Joseph Lee

Abstract

Figures

Figure 1.
Figure 1.
Réflexe d’étirement monosynaptique
Figure 2.
Figure 2.
Stratégies d’évaluation de la spasticité SP—sclérose en plaques

References

    1. Bar-On L, Molenaers G, Aertbeliën E, Van Campenhout A, Feys H, Nuttin B, et al. Spasticity and its contribution to hypertonia in cerebral palsy. BioMed Res Int. 2015;2015:317047. Publ. en ligne du 11 janv. 2015.
    1. Adams MM, Hicks AL. Spasticity after spinal cord injury. Spinal Cord. 2005;43(10):577–86.
    1. Fleuren JF, Voerman GE, Snoek GJ, Nene AV, Rietman JS, Hermens HJ. Perception of lower limb spasticity in patients with spinal cord injury. Spinal Cord. 2009;47(5):396–400. Publ. en ligne du 9 déc. 2008.
    1. Sosnoff JJ, Gappmaier E, Frame A, Motl RW. Influence of spasticity on mobility and balance in persons with multiple sclerosis. J Neurol Phys Ther. 2011;35(3):129–32.
    1. Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012;43(11):3132–6. Publ. en ligne du 13 sept. 2012.
    1. Sommerfeld DK, Eek EUB, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35(1):134–9. Publ. en ligne du 18 déc. 2003.
    1. Graham LA. Management of spasticity revisited. Age Ageing. 2013;42(4):435–41.
    1. Bhimani R, Anderson L. Clinical understanding of spasticity: implications for practice. Rehabil Res Pract. 2014;2014:279175. Publ. en ligne du 4 sept. 2014.
    1. Bavikatte G, Gaber T. Approach to spasticity in general practice. Br J Med Pract. 2009;2(3):29–34.
    1. Biering-Sørensen F, Nielsen JB, Klinge K. Spasticity-assessment: a review. Spinal Cord. 2006;44(12):708–22. Publ. en ligne du 25 avr.
    1. Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27(1–2):2–6.
    1. Nene AV, Rainha Campos A, Grabljevec K, Lopes A, Skoog B, Burns AS. Clinical assessment of spasticity in people with spinal cord damage: recommendations from the Ability Network, an international initiative. Arch Phys Med Rehabil. 2018;99(9):1917–26. Publ. en ligne du 10 févr. 2018.
    1. Nair KP, Marsden J. The management of spasticity in adults. BMJ. 2014;349:g4737.
    1. Fleuren JF, Nederhand MJ, Hermens HJ. Influence of posture and muscle length on stretch reflex activity in poststroke patients with spasticity. Arch Phys Med Rehabil. 2006;87(7):981–8.
    1. He J. Stretch reflex sensitivity: effects of postural and muscle length changes. IEEE Trans Rehabil Eng. 1998;6(2):182–9.
    1. Kheder A, Nair KP. Spasticity: pathophysiology, evaluation and management. Pract Neurol. 2012;12(5):289–98.
    1. Mahoney JS, Engebretson JC, Cook KF, Hart KA, Robinson-Whelen S, Sherwood AM. Spasticity experience domains in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88(3):287–94.
    1. Johnson GR. Outcome measures of spasticity. Eur J Neurol. 2002;9(Suppl 1):10–6.
    1. Rabchevsky AG, Kitzman PH. Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury. Neurotherapeutics. 2011;8(2):274–82.
    1. Elbasiouny SM, Moroz D, Bakr MM, Mushahwar VK. Management of spasticity after spinal cord injury: current techniques and future directions. Neurorehabil Neural Repair. 2010;24(1):23–33. Publ. en ligne du 1 sept. 2009.
    1. LiverTox . Tizanidine. Case reports. Case 1. Acute hepatocellular injury with jaundice after tizanidine therapy. Bethesda, MD: National Institutes of Health; 2017. Accessible à : . Réf. du 4 sept.
    1. LiverTox . Dantrolene. Case reports. Case 1. Fatal progressive liver disease after a 12 week course of dantrolene. Bethesda, MD: National Institutes of Health; 2017. Accessible à : . Réf. du 4 sept.
    1. Middleton JW, Leong G, Mann L. Management of spinal cord injury in general practice - part 2. Aust Fam Physician. 2008;37(5):331–2. 335–8.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren